We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$31.3M
Cap. Flow
+$17.7M
Cap. Flow %
14.26%
Top 10 Hldgs %
30.99%
Holding
124
New
34
Increased
26
Reduced
39
Closed
14

Top Buys

Rank Stock Value
1
UBX
Unity Biotechnology
UBX
+$4.51M
2
SPOT icon
Spotify
SPOT
+$1.47M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$1.31M
4
CNC icon
Centene
CNC
+$1.21M
5
APTX
Aptinyx Inc. Common Stock
APTX
+$1.17M

Top Sells

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.52M
3
MSFT icon
Microsoft
MSFT
+$2.51M
4
BAX icon
Baxter International
BAX
+$1.81M
5
BOX icon
Box
BOX
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 44.55%
2 Technology 12.71%
3 Communication Services 9.85%
4 Consumer Discretionary 3.5%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVA icon
26
DaVita
DVA
$11.5B
$1.4M 1.13%
20,167
+9,548
+90% +$638K
A icon
27
Agilent Technologies
A
$39.9B
$1.38M 1.12%
22,338
+4,335
+24% +$283K
HOLX
28
DELISTED
Hologic
HOLX
$1.35M 1.09%
33,991
+4,599
+16% +$177K
TWTR
29
DELISTED
Twitter, Inc.
TWTR
$1.34M 1.08%
30,629
-18,303
-37% -$642K
AMZN icon
30
Amazon
AMZN
$2.94T
$1.33M 1.07%
15,660
-180
-1% -$14.3K
DBX icon
31
Dropbox
DBX
$8.06B
$1.32M 1.06%
40,603
+22,748
+127% +$712K
BAX icon
32
Baxter International
BAX
$14B
$1.29M 1.05%
17,532
-25,619
-59% -$1.81M
CNC icon
33
Centene
CNC
$31.7B
$1.29M 1.04%
+20,968
New +$1.21M
MSGS icon
34
Madison Square Garden
MSGS
$9.43B
$1.29M 1.04%
+5,821
New +$1.08M
ESPR
35
DELISTED
Esperion Therapeutics
ESPR
$1.26M 1.02%
32,248
+16,138
+100% +$815K
PCRX icon
36
Pacira BioSciences
PCRX
$1.02B
$1.23M 0.99%
38,244
+14,446
+61% +$499K
CLVS
37
DELISTED
Clovis Oncology, Inc.
CLVS
$1.22M 0.99%
+26,864
New +$1.31M
RVTY icon
38
Revvity
RVTY
$12.7B
$1.15M 0.93%
15,717
-93
-0.6% -$6.98K
APTX
39
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.15M 0.92%
+54,773
New +$1.17M
MDCO
40
DELISTED
Medicines Co
MDCO
$1.13M 0.91%
30,693
-4,287
-12% -$139K
ATVI
41
DELISTED
Activision Blizzard
ATVI
$1.12M 0.9%
14,664
+572
+4% +$40.5K
PYPL icon
42
PayPal
PYPL
$51.1B
$1.12M 0.9%
13,404
-9,739
-42% -$776K
MYOK
43
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$1.11M 0.9%
22,431
+9,760
+77% +$473K
EA icon
44
Electronic Arts
EA
$1.1M 0.89%
+7,786
New +$1.01M
SPGI icon
45
S&P Global
SPGI
$119B
$1.1M 0.89%
+5,378
New +$1.06M
HCA icon
46
HCA Healthcare
HCA
$88.5B
$1.07M 0.87%
10,480
-1,734
-14% -$175K
TCOM icon
47
Trip.com Group
TCOM
$29.1B
$1.05M 0.85%
+22,095
New +$998K
PEN icon
48
Penumbra
PEN
$12.8B
$978K 0.79%
7,080
-1,538
-18% -$219K
ONCE
49
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$953K 0.77%
11,511
+2,513
+28% +$194K
MMSI icon
50
Merit Medical Systems
MMSI
$5.24B
$921K 0.74%
17,994
+7,796
+76% +$386K
1
2
3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Partner Investment Management held 124 positions worth $124M, up 34% from $92.6M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Partner Investment Management deployed $17.7M of net new capital in Q2 2018, opening 34 new positions and adding to 26 existing holdings. Its largest new stake was Unity Biotechnology: 30,876 shares worth $4.08M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 57% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Allena Pharmaceuticals, an estimated $4M trimmed.

  • Partner Investment Management's largest Q2 2018 buy was Unity Biotechnology: 30,876 shares worth $4.08M.
  • Partner Investment Management added most to Alphabet (Google) Class A in Q2 2018, an estimated $1.12M increase.
  • Partner Investment Management's biggest Q2 2018 reduction was Allena Pharmaceuticals, cutting an estimated $4M.
  • Partner Investment Management fully exited Bristol-Myers Squibb in Q2 2018, selling an estimated $3.52M.
  • Partner Investment Management's ten largest holdings make up 31% of its $124M portfolio in Q2 2018.
  • Partner Investment Management opened 34 new positions and closed 14 in Q2 2018.
  • Partner Investment Management's portfolio value rose 34% quarter-over-quarter to $124M.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.